Administration of Ascorbic Acid and an Aldose Reductase Inhibitor (Tolrestat) in Diabetes: Effect on Urinary Albumin Excretion

Publisher： Karger

E-ISSN： 2235-3186|80|3|277-284

ISSN： 1660-8151

Source： Nephron, Vol.80, Iss.3, 1998-11, pp. : 277-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Cerivastatin on Urinary Albumin Excretion and Plasma Endothelin-1 Concentrations in Type 2 Diabetes Patients with Microalbuminuria and Dyslipidemia

By  

American Journal of Nephrology, Vol. 21, Iss. 6, 2001-12 ,pp. : 449-454

Karger

Access to resources Recommend Favorite

Inhibitory Effect of Ibudilast on Urinary Albumin Excretion in Type 2 Diabetes mellitus with Microalbuminuria

By  

Nephron, Vol. 90, Iss. 2, 2002-01 ,pp. : 154-157

Karger

Access to resources Recommend Favorite

Relationship between Urinary Albumin Excretion and Glomerular Filtration Rate in Normotensive, Nonproteinuric Patients with Type 2 Diabetes mellitus

By  

Nephron, Vol. 86, Iss. 1, 2000-08 ,pp. : 36-43

Karger

Access to resources Recommend Favorite

Effect of Granulocyte and Monocyte Adsorption Apheresis on Urinary Albumin Excretion and Plasma Endothelin-1 Concentration in Patients with Active Ulcerative Colitis

By  

Blood Purification, Vol. 22, Iss. 6, 2005-01 ,pp. : 499-504

Karger

Access to resources Recommend Favorite

Effect of Dilazep Dihydrochloride on Urinary Albumin Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease

By  

Nephron, Vol. 88, Iss. 1, 2001-04 ,pp. : 80-82

Karger

Access to resources Recommend Favorite